肿瘤细胞治疗研究
DISEASE HUB
FOR TREATMENT
现在就能报名的（招募中）排在最前，共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov、CDE 与 ChiCTR 公开登记。能否入组、费用与可及性，以登记原文和主治医生判断为准。
FOR RESEARCH
CD33(KO)-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia.
Loop CAR 赋予 UCB-NK 细胞和 hPSC-iNK 细胞更强的针对 CD33 + MSLN + 肿瘤细胞的细胞毒性。
Mesothelin-targeted CAR-NK Cells Derived From Induced Pluripotent Stem Cells Have a High Efficacy in Killing Triple-negative Breast Cancer Cells as Sh
MEMBER ACCOUNT
登录成功会直接打开下一页。
